Cost-Effectiveness Analysis of Pneumococcal Vaccination for Elderly Individuals in The Netherlands
- 1 January 2001
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 19 (2) , 215-222
Abstract
Objective: To assess the cost effectiveness (net costs per life year gained) of pneumococcal vaccination of elderly individuals aged 65 years and over in The Netherlands. Design and setting:A...Keywords
This publication has 24 references indexed in Scilit:
- Temporary Increase in Incidence of Invasive Infection Due to Streptococcus pneumoniae in the NetherlandsClinical Infectious Diseases, 1999
- Economic Evaluation of Influenza VaccinationPharmacoEconomics, 1999
- Cost-effectiveness of vaccination against pneumococcal pneumonia in The NetherlandsEuropean Journal of Public Health, 1997
- Preventing Pneumococcal Bacteremia in Patients at RiskArchives of internal medicine (1960), 1995
- Efficacy of Pneumococcal Vaccination in AdultsArchives of internal medicine (1960), 1994
- Pneumococcal Polysaccharide Vaccine EfficacyJAMA, 1993
- Standardizing Methodologies for Economic Evaluation in Health Care: Practice, Problems, and PotentialInternational Journal of Technology Assessment in Health Care, 1993
- Discounting and health benefitsHealth Economics, 1992
- The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide VaccineNew England Journal of Medicine, 1991
- Probabilistic Sensitivity Analysis Using Monte Carlo SimulationMedical Decision Making, 1985